Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POMGNT2 antisense RNA 1 (POMGNT2-AS1) is a long non-coding RNA identified as an antisense transcript at the POMGNT2 gene locus. In general, antisense RNAs regulate gene expression—often by interacting with the sense (protein-coding) transcript either pre- or post-transcriptionally. Their biological impact can include modulation of chromatin structure, transcription, or mRNA stability and translation, typically in a locus-specific (cis) manner. However, for POMGNT2-AS1, no detailed functional data or disease relevance is currently documented. It is not a protein target (enzyme, receptor, transporter, etc.), but a regulatory RNA likely involved in modulating expression of the POMGNT2 gene or nearby loci. The functional implications of POMGNT2-AS1 itself have not been specifically characterized; most information about antisense RNAs comes from studies of the general class. POMGNT2 (the sense gene) is a protein-coding gene encoding a glycosyltransferase implicated in muscular dystrophies, but POMGNT2-AS1 refers solely to its antisense RNA, which behaves as a non-coding regulatory molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POMGNT2 antisense RNA 1 (POMGNT2-AS1).